N
Nasus Pharma Ltd.NSRX
Nasus Pharma is a clinical-stage pharmaceutical company developing a number of intranasal powder products addressing acute medical conditions in the community. NS002, Nasus Pharma's intranasal powder Epinephrine product candidate is being developed as a needle-free alternative to Epinephrine autoinjectors for patients with anaphylaxis. Intranasal administration is most suitable for those situations in which rapid drug delivery is required and offers needle-free, easy-to-use.
US StocksHealthcareGrowth Stocks
NSRX Price Trend
Nasus Pharma Ltd. · Full TradingView Chart
NASDAQ:NSRX